Victory Capital Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,473
| Closed | -$1.73M | – | 2705 |
|
|
2022
Q4 | $1.73M | Buy |
4,473
+1,123
| +34% | +$434K | ﹤0.01% | 1495 |
|
|
2022
Q3 | $1.13M | Sell |
3,350
-366
| -10% | -$123K | ﹤0.01% | 1672 |
|
|
2022
Q2 | $1.22M | Buy |
+3,716
| New | +$1.22M | ﹤0.01% | 1655 |
|
|
2022
Q1 | – | Sell |
-442
| Closed | -$194K | – | 2827 |
|
|
2021
Q4 | $194K | Buy |
442
+8
| +2% | +$3.51K | ﹤0.01% | 2488 |
|
|
2021
Q3 | $242K | Sell |
434
-100
| -19% | -$55.8K | ﹤0.01% | 2454 |
|
|
2021
Q2 | $274K | Sell |
534
-722
| -57% | -$370K | ﹤0.01% | 2447 |
|
|
2021
Q1 | $982K | Buy |
1,256
+200
| +19% | +$156K | ﹤0.01% | 1926 |
|
|
2020
Q4 | $575K | Sell |
1,056
-59
| -5% | -$32.1K | ﹤0.01% | 2011 |
|
|
2020
Q3 | $511K | Sell |
1,115
-418
| -27% | -$192K | ﹤0.01% | 1946 |
|
|
2020
Q2 | $944K | Sell |
1,533
-1,534
| -50% | -$945K | ﹤0.01% | 1755 |
|
|
2020
Q1 | $1.46M | Buy |
3,067
+1,397
| +84% | +$664K | ﹤0.01% | 1723 |
|
|
2019
Q4 | $969K | Buy |
1,670
+48
| +3% | +$27.9K | ﹤0.01% | 1765 |
|
|
2019
Q3 | $1.07M | Buy |
1,622
+1,582
| +3,955% | +$1.04M | ﹤0.01% | 1683 |
|
|
2019
Q2 | $31K | Hold |
40
| – | – | ﹤0.01% | 1777 |
|
|
2019
Q1 | $28K | Hold |
40
| – | – | ﹤0.01% | 1737 |
|
|
2018
Q4 | $19K | Sell |
40
-7
| -15% | -$3.33K | ﹤0.01% | 1743 |
|
|
2018
Q3 | $41K | Buy |
+47
| New | +$41K | ﹤0.01% | 1735 |
|